CoSyne Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 13

CoSyne Therapeutics General Information

Description

Operator of an AI-powered drug discovery company designed to accelerate the development of precision medicines for brain diseases. The company utilizes polymathic artificial intelligence and vertically integrated research processes to identify and develop therapeutic candidates, enabling healthcare providers to treat patients with underserved neurological conditions and brain cancer more effectively.

Contact Information

Website
www.cosyne.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Sheraton Street
  • WeWork Medius House
  • London W1F 8BH
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2 Sheraton Street
  • WeWork Medius House
  • London W1F 8BH
  • England, United Kingdom

CoSyne Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoSyne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Jan-2026 Completed Generating Revenue
6. Early Stage VC 08-Aug-2024 Completed Generating Revenue
5. Early Stage VC 20-May-2022 Completed Generating Revenue
4. Grant 01-Jan-2022 Completed Generating Revenue
3. Early Stage VC 03-Sep-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view CoSyne Therapeutics’s complete valuation and funding history, request access »

CoSyne Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 Preferred
Seed Preferred
Seed Preferred
Ordinary 15,470 $0.000013 $4.37 $4.37 1x $4.37 0.24%
Ordinary 268,537 $0.000013 $3.46 $3.46 1x $3.46 4.22%
To view CoSyne Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CoSyne Therapeutics Patents

CoSyne Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025158382-A1 Vector compositions for guide nucleic acid delivery and uses thereof Pending 26-Jan-2024
WO-2025104702-A1 Perturbation-linked genetic profile analysis Inactive 17-Nov-2023
WO-2025022355-A1 Methods of barcoding single cells and cellular subpopulations and uses thereof Inactive 25-Jul-2023
WO-2024161359-A2 Compound representation and property analysis at scale Inactive 01-Feb-2023
WO-2024161359-A3 Compound representation and property analysis at scale Inactive 01-Feb-2023 G16C20/30
To view CoSyne Therapeutics’s complete patent history, request access »

CoSyne Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoSyne Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arc Ventures (United States) Venture Capital Minority
B&Y Venture Partners Venture Capital Minority
Montage Ventures Venture Capital Minority
Amino Collective Venture Capital Minority
Backed Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

CoSyne Therapeutics FAQs

  • When was CoSyne Therapeutics founded?

    CoSyne Therapeutics was founded in 2021.

  • Where is CoSyne Therapeutics headquartered?

    CoSyne Therapeutics is headquartered in London, United Kingdom.

  • What is the size of CoSyne Therapeutics?

    CoSyne Therapeutics has 16 total employees.

  • What industry is CoSyne Therapeutics in?

    CoSyne Therapeutics’s primary industry is Drug Discovery.

  • Is CoSyne Therapeutics a private or public company?

    CoSyne Therapeutics is a Private company.

  • What is CoSyne Therapeutics’s current revenue?

    The current revenue for CoSyne Therapeutics is .

  • How much funding has CoSyne Therapeutics raised over time?

    CoSyne Therapeutics has raised $13M.

  • Who are CoSyne Therapeutics’s investors?

    Arc Ventures (United States), B&Y Venture Partners, Montage Ventures, Amino Collective, and Backed are 5 of 13 investors who have invested in CoSyne Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process